The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among patients undergoing colonoscopy, according to a study published in the June issue of the American Journal of Gastroenterology. Rebecca Yao, M.D., M.P.H., from the Mayo Clinic in Rochester, Minnesota, and colleagues conducted a retrospective cohort study of patients who underwent screening or surveillance colonoscopy at a large academic medical center to examine whether use of GLP-1 RA is associated with decreased quality of bowel preparation. Patients Read More